Cosmax BTI Q1 2026 Consolidated Net Income of KRW 19.2B Exceeds Full Year 2025

Q1 2026 consolidated revenue KRW 205.1B, operating profit KRW 16.4B, net income KRW 19.2B (exceeding full year 2025 net income of KRW 18.7B)
Strong performance from key subsidiaries: Cosmax NBT revenue KRW 72.6B (+40.7% YoY), Cosmax Bio KRW 39.7B (+26.8% YoY)
Global expansion of health functional food ODM business, increasing overseas sales (Cosmax NBT 63% from abroad)
Differentiation with 15 individually approved raw materials (Cosmax Bio 6, Cosmax NBT 9)
After reporting date (Apr 13, 2026), subsidiary Cosmax NBT signed merger agreement with Cosmax NS
Consolidated assets KRW 1.05T, liabilities KRW 733.9B, equity KRW 316.2B (debt ratio 232%)
Net income attributable to parent KRW 14.1B, basic EPS KRW 1,477